Cyclophosphamide: Effect on Experimental Allergic Encephalomyelitis in Lewis Rats

No abstract is available for this paper.

• Publication year

  1969

• Venue

  Science

• Publication date

  1969-07-11

• Fields of study

  Medicine

• Identifiers
  DOI 10.1126/science.165.3889.191PMID 5787160
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Immunologic unresponsiveness, immunity and enhancement in experimental allergic encephalomyelitis.

  1968cited by this paper
• Heparin inhibition of histamine release and its relation to calcium.

  1967cited by this paper
• Immunologic unresponsiveness to allergic thyroiditis in guinea pigs.

  1967cited by this paper
• Cyclophosphamide Inhibition of Experimental Allergic Encephalomyelitis in Wistar Rats.∗

  1967cited by this paper
• SUPPRESSION OF EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS BY ANTIMETABOLITIES.

  1965cited by this paper
• SUPPRESSION OF EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS BY ANTIMETABOLITES

  1965cited by this paper
• A COMPARISON OF THE EFFECTS OF SELECTED CYTOTOXIC AGENTS ON ALLOGENEIC SKIN GRAFT SURVIVAL IN RATS.

  1965cited by this paper
• Suppression of Experimental Allergic Encephalomyelitis by Cytotoxic Drugs

  1963cited by this paper
• Methotrexate: Suppression of Experimental Allergic Encephalomyelitis

  1963cited by this paper
• EFFECT OF WHOLE BODY X-IRRADIATION ON INDUCTION OF ALLERGIC ENCEPHALOMYELITIS IN RATS.

  1963cited by this paper
• Studies of induction of allergic encephalomyelities in rats and guinea pigs without the use of Mycobacteria.

  1962cited by this paper
• Progress in Allergy.

  1949cited by this paper

• Passive transfer of allergic encephalomyelitis in rats: a tool for drug mechanism studies and detecting late-acting immunosuppressants

  2019cites this paper
• The Experimental Basis for Hematopoietic Cell Transplantation for Autoimmune Diseases

  2016cites this paper
• Treatment of an autoimmune encephalomyelitis mouse model with nonmyeloablative conditioning and syngeneic bone marrow transplantation

  2011cites this paper
• Cyclophosphamide Treatment of MS: Current Therapeutic Approaches and Treatment Regimens.

  2010cites this paper
• Immunosuppressive therapy for multiple sclerosis.

  2005cites this paper
• Effects of cyclophosphamide on lesions induced by persistent LCM virus infection in gnotobiotic mice

  2005cites this paper
• Stabilization of rapidly worsening multiple sclerosis for 36 months in patients treated with interferon beta plus cyclophosphamide followed by interferon beta

  2004cites this paper
• Hematopoietic stem cell transplantation in multiple sclerosis: experimental evidence to rethink the procedures

  2004cites this paper
• Contrasting murine models of MS.

  2004cites this paper
• Immunosuppressive treatment in multiple sclerosis.

  2004cites this paper
• Treatment of multiple sclerosis with cyclophosphamide: critical review of clinical and immunologic effects

  2002cites this paper
• Passive Transfer of Experimental Autoimmune Labyrinthitis

  2000cites this paper
• Effect of open label pulse cyclophosphamide therapy on MRI measures of disease activity in five patients with refractory relapsing-remitting multiple sclerosis.

  1999cites this paper
• Elevated interleukin-12 in progressive multiple sclerosis correlates with disease activity and is normalized by pulse cyclophosphamide therapy.

  1998cites this paper
• Selective suppression of antigen‐specific Th2 cells by continuous micro‐dose oral tolerance

  1998cites this paper
• Structural elucidation and conformational properties of the immunomodulator linomide.

  1998cites this paper
• Suppression of experimental autoimmune encephalomyelitis (EAE) by intraperitoneal administration of soluble myelin antigens in Wistar rats.

  1997cites this paper
• Experimental autoimmune encephalomyelitis: Antigen‐induced inhibition of biochemical and immunohistological alterations

  1996cites this paper
• Immunotherapy in multiple sclerosis, Part 2.

  1995cites this paper
• Immunological tolerance to a defined myelin basic protein antigen administered intrathymically.

  1994cites this paper
• Inhibition of acute, experimental autoimmune encephalomyelitis by the synthetic immunomodulator linomide

  1993cites this paper
• Treatment of chronic-relapsing experimental autoimmune encephalomyelitis with the synthetic immunomodulator linomide (quinoline-3-carboxamide).

  1993cites this paper
• Prevention and reversal of adoptively transferred, chronic relapsing experimental autoimmune encephalomyelitis with a single high dose cytoreductive treatment followed by syngeneic bone marrow transplantation.

  1993cites this paper
• Heart rate and blood pressure changes during radiofrequency irradiation and environmental heating.

  1992cites this paper
• Comparative effects of tetrandrine and berbamine on acute and relapsing experimental allergic encephalitis in Lewis rats.

  1992cites this paper
• Suppression of experimental autoimmune encephalomyelitis by gallium nitrate.

  1992cites this paper
• Chronic-relapsing experimental autoimmune encephalomyelitis (CR-EAE): treatment and induction of tolerance, with high dose cyclophosphamide followed by syngeneic bone marrow transplantation.

  1992cites this paper
• Protective effect of transforming growth factor beta 1 on experimental autoimmune diseases in mice.

  1991cites this paper
• Oral tolerance in experimental autoimmune encephalomyelitis. III. Evidence for clonal anergy.

  1991cites this paper
• Reversal of autoimmune encephalomyelitis by membranes presenting myelin basic protein‐associated class II MHC molecule as an approach to immunotherapy of organ‐specific autoimmune diseases

  1990cites this paper
• [Intensive immunosuppression in progressive multiple sclerosis. An open study comparing 3 groups: cyclophosphamide, cyclophosphamide-plasmapheresis and control subjects. Results after 3 years].

  1989cites this paper
• Restricted use of T cell receptor V genes in murine autoimmune encephalomyelitis raises possibilities for antibody therapy.

  1988cites this paper
• Experimental Allergic Encephalomyelitis, Rat

  1988cites this paper
• T-Lymphocyte subpopulations in multiple sclerosis —Do they help to judge immunosuppressive therapy?

  1988cites this paper
• Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein and its fragments.

  1987cites this paper
• The use of cyclophosphamide to treat multiple sclerosis.

  1987cites this paper
• Experimental autoimmunity.

  1986cites this paper
• Unresponsiveness to experimental allergic encephalomyelitis in Lewis rats pretreated with complete Freund's adjuvant.

  1985cites this paper
• The effect of cyclophosphamide on T lymphocytes and T lymphocyte subsets in patients with chronic progressive multiple sclerosis

  1984cites this paper
• Experimental Allergic Encephalomyelitis ‐ Susceptibility and Suppression

  1981cites this paper
• Experimental allergic encephalomyelitis: activation of suppressor T lymphocytes by a modified sequence of the T effector determinant.

  1981cites this paper
• Experimental allergic encephalomyelitis: suppression with SD-170, a new synthetic drug.

  1981cites this paper
• Induction of experimental allergic encephalomyelitis in genetically resistant strains of mice

  1980cites this paper
• Analysis of autoimmunity through experimental models of thyroiditis and allergic encephalomyelitis.

  1980cites this paper
• Effect of cyclophosphamide on suppressor cell activity in mice unresponsive to EAE.

  1979cites this paper
• Prolonged azathioprine treatment of non-remitting multiple sclerosis

  1979cites this paper
• Does cyclophosphamide induce bladder cancer?

  1978cites this paper
• Suppression by essential fatty acids of experimental allergic encephalomyelitis is abolished by indomethacin.

  1978cites this paper
• A study of maternal lymphoid organs and the progeny following treatment with immunomodulating agents during pregnancy.

  1977cites this paper
• [Experience with the use of cyclophosphamide in multiple sclerosis].

  1977cites this paper
• Clinical effects of cyclophosphamide in Guillain-Barré polyneuritis.

  1976cites this paper
• Modifications in the establishment of allergic encephalomyelitis (EAE) in rats; an improved assay for immunosuppressant drugs

  1976cites this paper
• Cyclophosphamide in exacerbations of multiple sclerosis. Therapeutic trial and a strategy for pilot drug studies.

  1975cites this paper
• Reversal of experimental allergic thyroiditis in cyclophosphamide-treated rats.

  1975cites this paper
• Evaluation of antithymocyte globulin in acute relapses of multiple sclerosis

  1974cites this paper
• Cyclophosphamide: use in practice.

  1974cites this paper
• Experimental allergic encephalomyelitis in cyclophosphamide-treated Lewis rats: Clinical remissions and relapses and effect of treatment on neuro-fibrin deposits

  1974cites this paper
• Lymphocyte deactivation by (potential immunosuppressant) alkylating metabolites of cyclophosphamide

  1974cites this paper
• Acute allergic encephalomyelitis (EAE) in the rat with special reference to immunologic and demyelinization effects.

  1973cites this paper
• Effect of adjuvant disease in rats on cyclophosphamide and isophosphamide metabolism.

  1973cites this paper
• The in vitro effect of cyclophosphamide on Col. MM virus replication and interferon production.

  1973cites this paper
• Immunosuppressive Therapy for Chronic Liver Disease

  1973cites this paper
• Therapeutic effects of melengestrol acetate, cyclophosphamide and palmitoyl cytarabine in established experimental allergic encephalomyelitis of rats.

  1973cites this paper
• Immunosuppression--agents, procedures, speculations and prognosis.

  1972cites this paper
• Cytotoxic drugs in treatment of nonmalignant diseases.

  1972cites this paper
• Treatment of Experimental Allergic Encephalomyelitis with Encephalitogenic Basic Proteins 1

  1972cites this paper
• Suppression of the Immune Response: Reversal of the Disease State with Antigen in Allergic Encephalomyelitis

  1972cites this paper
• The chemical and immunologic properties of the basic A1 protein of myelin.

  1972cites this paper
• Treatment of experimental allergic encephalomyelitis in the rabbit.

  1972cites this paper
• Immunosuppressive agents.

  1972cites this paper
• The influence of anti-inflammatory and immunosuppressant drugs on Nystatin induced oedema.

  1971cites this paper
• Prevention of experimental allergic encephalomyelitis with cobra venom factor.

  1971cites this paper
• Cyclophosphamide therapy in Wegener's granulomatosis.

  1971cites this paper
• Cyclophosphamide treatment of experimental allergic encephalomyelitis in Lewis rats.

  1971cites this paper
• Chemical prevention of experimental allergic encephalomyelitis in rats: a quantitative evaluation of steroids and various non-steroid drugs.

  1971cites this paper
• The influence of cinanserin and selected pharmacologic agents on experimental allergic encephalomyelitis (EAE).

  1971cites this paper
• Cyclosphosphamide inhibition of experimental allergic thyroiditis and thyroid antibody production in rats.

  1971cites this paper
• The use of chemotherapeutic agents in the treatment of non-neoplastic diseases.

  1971cites this paper
• Rifampicin and alanosine inhibition of adjuvant arthritis in rats

  1971cites this paper
• Prevention of experimental allergic encephalomyelitis with cobra venom factor.

  1971cites this paper
• Chapter 25. Non-steroidal Anti-inflammatory Agents

  1970cites this paper
• Suppression of thyroid lesions in rabbits by treatment with cyclophosphamide after the induction of thyroiditis.

  1970cites this paper
• The uvea.

  1970cites this paper
• Immunosuppression and the Guillain-Barré syndrome.

  1970cites this paper
• Studies of cyclophosphamide suppression of experimental allergic encephalomyelitis in Wistar rats.

  1969cites this paper
• The effect of cyclophosphamide on experimental allergic encephalomyelitis in rats.

  1969cites this paper
• The effect of cyclophosphamide on experimental allergic encephalomyelitis in rats.

  1969cites this paper